GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Asset Impairment Charge

Kimia Biosciences (BOM:530313) Asset Impairment Charge : ₹0.00 Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Asset Impairment Charge?

Kimia Biosciences's Asset Impairment Charge for the six months ended in . 20 was ₹0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was ₹0.00 Mil.


Kimia Biosciences Asset Impairment Charge Historical Data

The historical data trend for Kimia Biosciences's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Asset Impairment Charge Chart

Kimia Biosciences Annual Data
Trend
Asset Impairment Charge

Kimia Biosciences Semi-Annual Data
Asset Impairment Charge

Kimia Biosciences Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was ₹0.00 Mil.


Kimia Biosciences Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines